A Phase I, Single Center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous AZD9742 in Healthy Male and Female Japanese Subjects.

Trial Profile

A Phase I, Single Center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous AZD9742 in Healthy Male and Female Japanese Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Aug 2010

At a glance

  • Drugs AZD 9742 (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Aug 2010 Actual patient number is 35 as reported by ClinicalTrials.gov.
    • 29 Jul 2010 Actual initiation date added to 1 Apr 2010 as reported by ClinicalTrials.gov.
    • 29 Jul 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top